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h i g h l i g h t s
 In lung transplant patients, open gastrostomy tube may result in less mortality than a percutaneous gastrostomy tube.
 In-hospital complications are less when lung transplant recipients receive open gastrostomy as compared to PEG.
 PEG in lung transplant recipients does not result in decreased length of stay when compared to open gastrostomy.
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a b s t r a c t
Introduction: Lung transplant patients require a high degree of immunosuppression, which can impair
wound healing when surgical procedures are required. We hypothesized that because of impaired
healing, lung transplant patients requiring gastrostomy tubes would have better outcomes with open
gastrostomy tube (OGT) as compared to percutaneous endoscopic gastrostomy tube (PEG).
Methods: The National Inpatient Sample (NIS) Database (2005e2010) was queried for all lung transplant
recipients requiring OGT or PEG.
Results: There were 215 patients requiring gastrostomy tube, with 44 OGT and 171 PEG. The two groups
were not different with respect to age (52.0 vs. 56.9 years, p ¼ 0.40) and Charlson Comorbidity Index (3.3
vs. 3.5, p ¼ 0.75). Incidence of acute renal failure was higher in the PEG group (35.2 vs. 11.8%, p ¼ 0.003).
Post-operative pneumonia, myocardial infarction, surgical site infection, DVT/PE, and urinary tract
infection were not different. Post-operative mortality was higher in the PEG group (11.2 vs. 0.0%,
p ¼ 0.02). Using multiple variable analysis, PEG tube was independently associated with mortality (HR:
1.94, 95%C.I: 1.45e2.58). Variables associated with survival included age, female gender, white race, and
larger hospital bed capacity.
Discussion: OGT may be the preferred method of gastric access for lung transplant recipients.
Conclusions: In lung transplant recipients, OGT results in decreased morbidity and mortality when
compared to PEG.
© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Lung transplantation remains an effective treatment option for
select patients with end-stage lung disease [1e5]. Some lung
transplant patients may go on to require enteral access due to being
physically incapable of eating or otherwise not able to meet their
nutritional requirements [6]. Percutaneous gastrostomy tube (PEG)
has become the method of choice for long term enteral access,
given its cost effectiveness and lower complication rate compared
to open surgical gastrostomy (OGT) [7,8]. However, lung transplant
patients present a unique challenge, as they require high doses of
* Corresponding author. Washington University in St. Louis, 660 S Euclid Ave,
Campus Box 8234, St. Louis, MO 63110, USA.
E-mail address: taghavis@wudosis.wustl.edu (S. Taghavi).
Contents lists available at ScienceDirect
Annals of Medicine and Surgery
journal homepage: www.annalsjournal .com
http://dx.doi.org/10.1016/j.amsu.2015.12.056
2049-0801/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Annals of Medicine and Surgery 5 (2016) 76e80
immunosuppression to prevent rejection. These same medications
have been proven to impair wound healing via various mechanisms
[9]. Open gastrostomy tube allows for suturing of the stomach to
the anterior abdominal wall, which may decrease the risk of
intraperitoneal leak as compared to PEG tube. To our knowledge,
there have been no studies comparing outcomes between PEG and
OGT in lung transplant patients. The goal of this study is to compare
postoperative morbidity and mortality between open surgical
gastrostomy and percutaneous endoscopic gastrostomy in lung
transplant recipients. We hypothesize that because of impaired
wound healing, lung transplant patients undergoing OGT would
have better outcomes as compared to PEG.
2. Materials and methods
2.1. Database
After approval from local institutional review board (IRB), the
National Inpatient Sample (NIS) Database, developed by the
Healthcare Cost and Utilization Project (HCUP), was utilized for this
study. This database contains data from approximately 7 million
hospital stays each year and is obtained from a stratiﬁed sample of
20% of non-federal United States hospitals. The NIS is the largest
publicly available, all payer, inpatient health care database in the
United States [10]. A self-weighting design reduces the margin of
error for estimates and delivers population based estimates. All of
our statistical analysis was based on this weighting design as
established in previous studies [11]. The NIS is a publically available
deidentiﬁed database and was therefore granted exempt status
from our IRB committee.
2.2. Study population
Adult lung transplant patients who underwent OGT or PEG tube
placement between 2005 and 2010 were initially identiﬁed by the
International Classiﬁcation of Disease, Ninth Revision (ICD-9)
diagnosis and Current Procedural Terminology (CPT) procedure
code. Patients were initially selected based on diagnosis code for
lung transplant (V42.6) and then separated into groups based on
the procedure code for open gastrostomy tube (43.19) and percu-
taneous gastrostomy tube (43.11).
2.3. Data and statistical analysis
The primary outcome was inpatient mortality after gastrostomy
tube placement. Secondary outcomes included in-hospital com-
plications, length of stay, and cost. Individual postoperative com-
plications were identiﬁed by ICD-9 codes as established in previous
studies [11]. Continuous and categorical variables were compared
with student's t-test and chi square analysis. All continuous vari-
ables are presented as mean ± standard deviation. Weighted fre-
quencies and weighted multiple variable logistic regression
analysis using clinically relevant variables were used to examine
post-operative complications and mortality. Covariates included in
the model were age, female sex, race, hospital bed size, Charlson
comorbidity index, and PEG tube placement. Odds ratio (OR) with
95% conﬁdence intervals were presented for each covariate. A p-
value less than 0.05 was considered statistically signiﬁcant. Data
was analyzed using SAS 9.2 software (SAS Institute, Cary, NC).
3. Theory
We hypothesize that because of impaired wound healing from
chronic immunosuppression, lung transplant patients undergoing
OGT would have better outcomes as compared to PEG. Because of
impaired wound healing, there is delayed formation of a ﬁbrotic
tract after placement of a PEG tube, which increases the risk of
intraabdominal tube dislodgement and intraabdominal leak.
Placement of an OGT allows for direct pexying of the anterior
gastric wall, which minimizes the risk of intraperitoneal leak and
results in better outcomes.
4. Results
4.1. Baseline characteristics
A total of 215 lung transplant patients underwent gastric enteral
access during the study period. Of these, 171 (79.5%) received a PEG
tube and 44 (20.5%) had an OGT. As seen in Table 1, the patients in
these two groups were not signiﬁcantly different with respect to
age (52.0 vs. 56.9 years, p ¼ 0.40), Charlson Comorbidity Index (3.3
vs. 3.5, p ¼ 0.75), and private payer status (37.5 vs. 32.9%, p ¼ 0.05).
Patients undergoing OGT were more likely to have a history of
peripheral vascular disease (4.7 vs. 11.9%, p ¼ 0.01). There was no
signiﬁcant difference in history of myocardial infarction (0.0 vs.
0.0%, p ¼ 0.99), congestive heart failure (14.6 vs. 11.9%, p ¼ 0.63),
cerebrovascular disease (0.0 vs. 11.9%, p ¼ 0.23), diabetes (33.3 vs.
22.7%, p¼ 0.16), and chronic renal disease (36.8 vs. 22.7%, p ¼ 0.08)
when comparing the two groups. The PEG cohort was more likely
to be male (66.3 vs. 45.3%, p ¼ 0.01) or Caucasian (94.3 vs. 88.1%,
p < 0.001) and less likely to be Hispanic (0.0 vs. 5.3%, p < 0.001).
4.2. Post-operative outcomes
As seen in Table 2, the PEG cohort had higher incidence of acute
renal failure when compared to the OGT group (35.2% vs. 11.8%,
p ¼ 0.003). Post-operative pneumonia, myocardial infarction, sur-
gical site infection, deep vein thrombosis (DVT), and pulmonary
embolus (PE) were not different when comparing the two groups.
As seen in Fig.1, length of stay (33.0 vs. 27.1 days, p¼ 0.63) and total
hospital charges ($203,023 vs. 294,679, p ¼ 0.45) were also similar.
4.3. Survival
Inpatient mortality was signiﬁcantly higher in the PEG group
compared to the OGT cohort (11.2% vs. 0%, p ¼ 0.02). As shown in
Table 3, using multiple variable analysis, placement of PEG tube
(OR: 1.94, 95%C.I: 1.45e2.58, p < 0.001) and increasing Charlson
Comorbidity Index (OR: 1.42, 95%C.I: 1.34e1.51, p < 0.001) were
signiﬁcantly associated with mortality. Variables associated with
survival included female sex (OR: 0.76, 95%C.I: 0.65e0.88,
p < 0.001), white race (OR: 0.75, 95%C.I: 0.64e0.87, p < 0.001), and
Table 1
Baseline characteristics of patients undergoing gastrostomy tube placement.
PEG (n ¼ 171) OGT (n ¼ 44) p value
Age 56.9 ± 29.8 52.0 ± 46.5 0.40
Charlson Comorbidity Index 3.50 ± 4.19 3.27 ± 4.24 0.75
History of myocardial infarction 0 (0.0) 0 (0.0) 0.99
History of congestive heart failure 25 (14.6) 5 (11.9) 0.63
History of peripheral vascular disease 4 (4.7) 5 (11.9) 0.01
History of cerebrovascular disease 0 (0.0) 5 (11.9) 0.23
History of diabetes 57 (33.3) 10 (22.7) 0.16
History of chronic renal disease 63 (36.8) 10 (22.7) 0.08
Male (%) 114 (66.3) 20 (45.3) <0.01
Caucasian (%) 162 (94.3) 39 (88.1) <0.001
Hispanic (%) 0 (0.0) 5 (11.9) <0.001
Other Race (%) 10 (5.7) 0 (0) <0.001
Private insurance (%) 64 (37.5) 14 (32.9) 0.055
Medicare (%) 78 (45.3) 15 (33.7) 0.055
Medicaid (%) 30 (17.2) 15 (33.4) 0.055
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admission to a hospital with larger patient capacity (more licensed
beds) (OR: 0.74, 95%C.I: 0.66e0.82, p < 0.001), and younger age
(OR: 0.98, 95%C.I: 0.97e0.99, p < 0.001).
5. Discussion
A feeding gastrostomy tube remains an effective way to obtain
enteral access in patients that are unable to eat or who cannot meet
their nutritional demands by intake volition. PEG has become the
method of choice for long term enteral access in the majority of
patients given its cost effectiveness and lower complication rate
compared to OGT [7,8,12]. However, lung transplant patients pose a
unique challenge, as they require high doses of immunosuppres-
sion, which have the unwanted side effect of impairing wound
healing. This impaired would healing may lead to increased risk of
intraperitoneal leakage with a PEG tube, while OGT allows for su-
ture ﬁxation of the stomach to the anterior abdominal wall, mini-
mizing this risk of intraabdominal leak. While many studies have
focused on improving outcomes and increasing donors for lung
transplant recipients [13e20], the best method of enteral access in
these patients has not been deﬁned.
This study demonstrates that placement of a PEG tube may
result in increased mortality in the lung transplant population.
While there were no deaths in the OGT group, inpatient mortality
was 11.2% in the PEG group. In addition, when controlling for other
variables, including age and comorbidities, placement of a PEG tube
was independently associated with mortality. The reason for
increased mortality in the patients receiving PEG tube is not
known. Prior studies have shown conﬂicting results when
comparing mortality from PEG to OGT, with some showing no
difference [21,22] and others showing better survival with PEG [23].
However, these studies did not examine outcomes of PEG and OGT
in chronically immunosuppressed patients. Placement of a PEG
tube relies on the formation of a ﬁbrotic tract over the PEG tube.
This tract prevents leakage of contents into the peritoneal cavity as
well as keeps the anterior portion of the stomach adherent to the
anterior abdominal wall. The high doses of immunosuppressive
medications required by lung transplant recipients may hinder this
process and increase the risk of tube dislodgement and intraperi-
toneal leak, which may lead to worse survival. Placement of an
open gastrostomy tube allows for direct surgical ﬁxation of the
stomach to the abdominal wall. This may help a tract form and
minimize the risk of intraperitoneal leak. Unfortunately, the inci-
dence of tube dislodgement and intraperitoneal leakage could not
be determined from the NIS database. Further studies are needed to
determine why lung transplant patients receiving OGT have better
survival.
Charlson Comorbidity Index was found to be associated with
increased mortality on multivariate analysis. This is not surprising
as comorbidities have clearly been shown to affect surgical out-
comes [24,25]. In addition, female gender and white ethnicity was
found to be associated with survival in lung transplant recipients.
This ﬁnding is consistent with previous studies [17,19]. While larger
hospital size as measured by number of beds has not been shown to
be associated with survival in previous studies, high volume
transplant centers are known to have better outcomes with
transplant recipients [26]. Large number of hospital beds may be a
marker of a high volume lung transplant center.
Previous studies have shown increased complications with OGT
as compared to PEG [8,21,22]; however, these studies did not
examine immunosuppressed patients and in the present study,
lung transplant recipients receiving PEG tube had greater incidence
of renal injury that those receiving OGT. This is the ﬁrst study to
date to make this ﬁnding. Further work is needed to determine the
reason for increased kidney injury in lung transplant recipients
receiving PEG. One possibility is that immunosuppressive protocols
were different between the two groups. Acute renal failure is a
known complication of immunosuppressive medications used for
lung transplant recipients. Unfortunately, immunosuppressive
protocols are not available in the NIS database. Future studies that
Table 2
Outcomes of patients undergoing gastrostomy tube placement.
PEG (n ¼ 171) OGT (n ¼ 44) p value
Mortality (%) 19 (11.2%) 0 (0%) 0.019
Acute kidney failure (%) 60 (35.2%) 5 (11.7) 0.002
Myocardial infarction (%) 0 (0%) 0 (0%) 0.99
Pneumonia (%) 0 (0%) 0 (0%) 0.99
DVT (%) 10 (5.6%) 0 (0%) 0.107
Pulmonary embolism (%) 9 (5.2%) 0 (0%) 0.123
Surgical site infection (%) 11 (6.3%) 0 (0%) 0.087
UTI (%) 0 (0%) 0 (0%) 0.99
Fig. 1. Comparison of (A) length of stay and (B) total hospital charges.
Table 3
Logistic regression examining variables associated with mortality.
Covariate Odds ratio 95% conﬁdence interval p value
PEG 1.94 1.45e2.58 <0.001
Female gender 0.76 0.65e0.88 <0.001
White race 0.75 0.64e0.87 <0.001
Age 0.98 0.97e0.99 <0.001
Larger hospital bed capacity 0.74 0.66e0.82 <0.001
Charlson Comorbidity Index 1.42 1.34e1.51 <0.001
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take into account immunosuppressive regiments are needed.While
tube dislodgement and intraperitoneal leak can ultimately lead to
renal injury, the limitations of the database does not allow us to
determine the reason for the observed renal injury.
Interestingly, previous studies have shown increased wound
infections in patients receiving OGT [21,22]. However, we found no
difference in surgical site infection when comparing PEG to OGT.
Other documented complications of OGT include internal leakage,
dehiscence, peritonitis, ﬁstula, and dislodgement [8]. Unfortunately
the incidence of these complications could not be determined using
the NIS database. Other in-hospital comorbidities examined in this
study included myocardial infarction, DVT, PE, and urinary tract
infection and were not found to be different when comparing the
PEG and OGTcohorts. These complications have not been examined
in previous studies investigating PEG and OGT.
One potential advantage of PEG is that it is a more cost-effective
procedure than OGT, as demonstrated in the trauma population [8].
In our study, there was no difference in total hospital charges when
comparing the PEG and OGT cohorts. While the procedural cost of a
PEG may be lower than that of an OGT [8], it is possible that the
increased complications observed in the PEG cohort leads to
increased total cost that offsets the more economical procedure.
However, the long-term cost-effectiveness of PEG as compared to
OGT has yet to be studied.
This study was not without limitation, including those inherent
to a retrospective analysis. These databases are conﬁned to in-
hospital events and may underestimate the true incidence of
mortality and other complications as theymay occur after the index
hospitalization. Long-term survival, morbidity, and cause of death
are not available in the database. In addition, it is not possible to
determine the number of intraabdominal complications or tube
dislodgements with the NIS database. This analysis is also depen-
dent on accurate coding of diagnoses, complications, and pro-
cedures and is therefore inherently subject to a reporting bias.
6. Conclusions
In conclusion, for lung transplant recipients, the placement of a
PEG tube results in increased morbidity and mortality. In addition,
placement of OGT in lung transplant recipients does not result in
increased length of stay or increased hospital charges. OGT may be
a better method of gastric access in lung transplant patients.
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